Kolexia
Simbsler Cecile Anatomie et cytologie
Simbsler Cecile
Anatomie et cytologie
Clinique Saint George
Nice, France
43 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Carcinome épidermoïde de la tête et du cou Carcinome épidermoïde Carcinomes Tumeurs du poumon Métastase tumorale Fatigue Malnutrition Carcinome verruqueux

Collaborateurs

Voir plus
Guigay Joel
Guigay Joel
Centre Antoine Lacassagne, Nice, France
Bourhis Jean
Bourhis Jean
Gustave-Roussy, Villejuif, France
Auperin Anne
Auperin Anne
Gustave-Roussy, Villejuif, France
Thariat Juliette
Thariat Juliette
Centre François-Baclesse, Caen, France

Industries

Voir plus
A+A
4 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
The Lancet. Healthy longevity   05 mars 2024
ELAN-UNFIT: Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation
Essai Clinique (Merck-Serono)   07 février 2024
Lung cancer mortality in the European cohort of titanium dioxide workers: a reanalysis of the exposure-response relationship.
Occupational and environmental medicine   02 mai 2022
Treatment of inoperable elderly head and neck cancer patients.
Current opinion in oncology   24 mars 2020
Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH)
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019
Personalized treatment according to geriatric assessment in first-line recurrent and/or metastatic (R/M) head and neck squamous cell cancer (HNSCC) patients aged 70 or over: ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019
Approach to the Patient with Recurrent/Metastatic Disease.
Current treatment options in oncology   25 juin 2019
Analyse longitudinale du support nutritionnel chez des patients primo traités pour un cancer des voies aérodigestives supérieures (VADS) au centre Antoine Lacassagne
Nutrition Clinique et Métabolisme   01 mars 2019
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.
Future oncology (London, England)   26 mars 2018
Regulatory identification of BPA as an endocrine disruptor: Context and methodology.
Molecular and cellular endocrinology   06 février 2018